PVLA Stock Price - Palvella Therapeutics, Inc. logo

PVLA Stock Price

Palvella Therapeutics, Inc.

$144.35
-$0.25(-0.17%)
51
Overall
40
Value
75
Tech
39
Quality
How is this score calculated?
Market Cap
$2.11B
Volume
211.07K
52W Range
$72.23 - $179.95
Target Price
$231.06

PVLA stock price is $144.35 (-0.17% on the day), giving Palvella Therapeutics, Inc. a market cap of $2.11B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

PVLA Stock Overview

Price
$144.35
Previous close
$144.60
Open
$145.47
Market cap
$2.11B
52-week range
$72.22 - $179.95
1-year price target
$231.06
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
51

About Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.

ABCD
1SymbolPriceChangeVol
2PVLA$144.35-0.2%211.07K
3
4
5
6

Get Palvella Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.